AGP Executive Report
Last update: an hour agoSleeping Sickness Breakthrough: DNDi says Africa’s new single-dose Acoziborole for human African trypanosomiasis can reach up to 96% success, aiming to make treatment more accessible in neglected communities. AI Skills Gap: A new warning from the US labour market suggests AI could reduce hiring for young workers in highly automatable roles—urging African employers to plan a talent pipeline before automation outpaces entry-level jobs. Guinea Health & Research: Liberia’s critically endangered chimpanzees—once used in hepatitis B vaccine experiments—are getting head-to-toe health checks at a sanctuary, with Guinea noted as the region’s chimp stronghold. Sickle Cell Production Push: WHO-backed hydroxyurea access is increasingly tied to local manufacturing and child-friendly formulations, with Senegal and Nigeria leading the “make it locally” shift. Guinea in Regional Tech Diplomacy: The Gambia and Guinea reaffirm stronger bilateral ties, including science and technology cooperation, as leaders sign a joint communiqué. Public Health in the Region: Guinea is among countries flagged in a Philippines temporary ban on foot-and-mouth disease–susceptible animal imports, citing lab-confirmed outbreaks. Conakry Conference: Guinea hosts an African conference on sexual and reproductive health and rights for adolescents, focusing on education, protection, and healthcare access amid crises. Ebola Update: DRC’s Ebola death toll rises to 3,007 with 6,186 cases reported, as vaccination and contact monitoring continue.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.